A Case Report of Adrenocorticotropic Hormone to Treat Recurrent Focal Segmental Glomerular Sclerosis Post-transplantation and Biomarker Monitoring

A Case Report of Adrenocorticotropic Hormone to Treat Recurrent Focal Segmental Glomerular Sclerosis Post-transplantation and Biomarker Monitoring

Background: Recurrent focal segmental glomerular sclerosis (rFSGS) in renal transplant recipients (RTR) is difficult to predict and treat. Early rFSGS is likely from circulating factors and preformed antibodies. Methods: We present the case of a 23-year-old white man who presented with rFSGS and a...

Full description

Bibliographic Details
Main Authors:	Anwar eSiddiq, Derek S. Larson, Nima eNaimi, Muhammad eAshraf, Nancy eCuliberk, Helen eLiapis, Changli eWei, Jochen eReiser, Daniel C. Brennan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-03-01
Series:	Frontiers in Medicine
Subjects:	Acute Kidney Injury podocyte Soluble urokinase plasminogen activator receptor (suPAR) albumin permeability factor angiotensin 1 receptor antibody recurrent focal segmental glomerular sclerosis
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmed.2015.00013/full

Similar Items

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction
by: Evangelos Terpos, et al.
Published: (2020-10-01)

Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR
by: Shirley Shuster, et al.
Published: (2018-10-01)

suPAR as a marker of infection in acute kidney injury – a prospective observational study
by: Anna Hall, et al.
Published: (2018-08-01)

The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine
by: Jan Simon Scharrenberg, et al.
Published: (2019-11-01)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
by: Jeppe Meyer, et al.
Published: (2018-02-01)

Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis
by: Yumeng Wen, et al.
Published: (2018-04-01)

Targeting uPAR in diabetic vascular pathologies*
by: Martyna Durak-Kozica, et al.
Published: (2019-12-01)

suPAR as a prognostic biomarker in sepsis
by: Donadello Katia, et al.
Published: (2012-01-01)

Primary Focal Segmental Glomerulosclerosis: Why Are Pieces of This Puzzle Still Missing?
by: Hernán Trimarchi
Published: (2015-07-01)

Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations : the SAfrEIC study / Anélda Smith
by: Smith, Anélda
Published: (2011)

Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations : the SAfrEIC study / Anélda Smith
by: Smith, Anélda
Published: (2011)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

Reassessing the Reassessment of suPAR in glomerular disease
by: Björn eMeijers, et al.
Published: (2015-01-01)

Diabetes Mellitus in the Transplanted Kidney
by: Vasil ePeev, et al.
Published: (2014-08-01)

SuPAR-based choice of the management strategy in kidney transplant recipients with infection
by: N. V. Rapetskaya, et al.
Published: (2020-10-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery
by: Jana C. Mossanen, et al.
Published: (2017-07-01)

Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor – β1 (TGF-β1) and potential effects on migration and invasion
by: Synnove Norvoll Magnussen, et al.
Published: (2017-05-01)

Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy
by: K. A. Rubina, et al.
Published: (2021-05-01)

Fibrinolytics: from the thrombolysis to the processes of blood vessels growth and remodeling, neurogenesis, carcinogenesis and fibrosis
by: V A Tkachuk, et al.
Published: (2019-09-01)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
by: Rabensteiner, Jasmin, et al.
Published: (2016-07-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva: um estudo piloto
by: Joana Silvestre, et al.
Published: (2019-01-01)

The Association between Plasma Levels of Intact and Cleaved uPAR Levels and the Risk of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer
by: Hein Vincent Stroomberg, et al.
Published: (2020-10-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

Lipids isolated from bone induce the migration of human breast cancer cells
by: Jeane Silva, et al.
Published: (2006-04-01)

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
by: A. Yarzábal, et al.
Published: (2000-09-01)

Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine
by: Yuan Hong, et al.
Published: (2019-04-01)

The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study
by: Ruizhao Li, et al.
Published: (2021-01-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors
by: María D. Valls, et al.
Published: (2021-04-01)

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia
by: Eman Qassim Ahmed, et al.
Published: (2020-01-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
by: Ery Olivianto, et al.
Published: (2019-01-01)

Studying the Activity of Fibroblast Growth Factor 18 and Urokinase Plasminogen Activator Receptor Promoters in Two Colon Cancer Cell Lines
by: Ladan Teimoori-Toolabi, et al.
Published: (2009-01-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Angela S. Koh, et al.
Published: (2017-11-01)

Activación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis aries
by: Omaira Cañas, et al.
Published: (2011-01-01)

Cannot write session to /tmp/vufind_sessions/sess_agpmkme9lmrp7031n7qoaihh7f